John Alam is a committed developer of innovative drugs targeting serious diseases, currently serving as the CEO and founder of a company focused on Alzheimer's disease. They previously held significant roles, including global head of Alzheimer’s & Aging R&D at Sanofi and Chief Medical Officer at Vertex Pharmaceuticals. Alam has led clinical development projects, notably the first disease-modifying drug for multiple sclerosis at Biogen. Additionally, Alam served on the Board of Directors for the Alliance for Aging Research and is a member of the Board of Overseers at WGBH. They hold an MD from Northwestern University and a degree in Chemical Engineering from the Massachusetts Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices